Reduced heart rate variability in patients with chronic obstructive pulmonary disease independent of anticholinergic or β-agonist medications

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 7, Issue 6, 2010, Pages 391-397

  Bédard, Marie Eve ^a   Marquis, Karine ^a   Poirier, Paul ^a,b   Provencher, Steeve ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Anticholinergic; Chronic obstructive pulmonary disease; FEV1; Heart rate variability; agonist

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BRADYCARDIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE VARIABILITY; HUMAN; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; TACHYCARDIA;

EID: 78650479900     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2010.528083     Document Type: Article

References (36)

1. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of Measurement, Physiological Interpretation, and Clinical Use. Circulation 1996 93 5 1043-1065.
2. Hon EH, Lee ST. Electronic evaluations of the fetal heart rate, patterns preceding fetal death: further observations. Am J Obstet Gynecol 1963; 87:814-826.
3. Wolf MM VG, Hunt D, Sloman JG. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978; 2:52-53.
4. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59(4):256-262.
5. Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu Rev Med 1999; 50:249-261.
6. Tsuji H, Larson MG, Venditti FJ, et al. Impact of reduced heart rate variability on risk for cardiac events: The Framingham Heart Study. Circulation 1996; 94(11):2850-2855.
7. Volterrani M, Scalvini S, Mazzuero G, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106(5):1432-1437.
8. Bartels MN, Jelic S, Ngai P, Basner RC, DeMeersman RE. High-frequency modulation of heart rate variability during exercise in patients with COPD. Chest 2003; 124(3):863-869.
9. Stewart AG, Waterhouse JC, Howard P. Cardiovascular auto-nomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur Respir J 1991; 4(10):1207-14.
10. Camillo CA, Pitta F, Possani HV, Barbosa MV, Marques DS, Cavalheri V, Probst VS, Brunetto AF. Heart rate variability and disease characteristics in patients with COPD. Lung 2008;186(6):393-401.
11. Pagani M, Lucini D, Pizzinelli P, Sergi M, Mela GS, Malliani A. Effects of aging and of chronic obstructive pulmonary disease on RR interval variability. J Auton Nerv Syst 1996; 59:125-132.
12. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, Van Weel C, Zielinski J. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2007; 176:532-555. (Pubitemid 47403272)
13. Macintyre N, Crapo RO, Viegi G, Johnson DC, Van Der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26(4):720-35.
14. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Van Der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005; 26(2):319-338.
15. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Van Der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26(3):511-522.
16. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, Van Der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005; 26(5):948-968.
17. Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG. Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in uncomplicated well-controlled men with type 2 diabetes. Metabolism 2003; 52:1056-1061.
18. Novak V, Novak P, De Champlain J, Le Blanc AR, Martin R, Nadeau R. Influence of respiration on heart rate and blood pressure fluctuations. J Appl Physiol 1993; 74(2):617-626.
19. Sanderson JE, Yeung LY, Yeung DT, Kay RL, Tomlinson B, Critchley JA, Woo KS, Bernardi L. Impact of changes in respiratory frequency and posture on power spectral analysis of heart rate and systolic blood pressure variability in normal subjects and patients with heart failure. Clin Sci 1996; 91(1):35-43.
20. Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG. Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in uncomplicated well-controlled men with type 2 diabetes. Metabolism 2003; 52:1056-1061.
21. Utemani K, Singer DH, McCraty R, Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol 1998; 31(3):593-601.
22. Guenard H. Respiration and aging. Rev Mal Respir 1998; 15(6):713-721.
23. Stein PK, Nelson P, Rottman JN, Howard D, Ward SM, Kleiger RE, Senior RM. Heart Rate Variability Reflects Severity of COPD in PiZ agr1-antitrypsin deficiency. Chest 1998; 113(2): 327-333.
24. Cekici L, Valipour A, Kohansal R, Burghuber OC. Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study. Br J Clin Pharmacol 2009; 67(4):394-402.
25. Jartti T, Kaila T, Tahvanainen K, Kuusela T, Vanto T, Välimäki I. The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis. Br J Clin Pharmacol 1997; 43(4):421-428.
26. Eryonucu B, Uzun K, Güler N, Bilge M. Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients. Eur Respir J 2001; 17:863-867.
27. Wallukat G. The β-adrenergic receptors. Herz 2002; 27(7): 683-690.
28. Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5(4):543-548.
29. Marquis K, Maltais F, Poirier P. Cardiovascular manifestations in patients with COPD. Rev Mal Respir 2008; 25(6):663-673.
30. Yildiz P, Tükek T, Akkaya V, Sözen AB, Yildiz A, Korkut F, Yilmaz V. Ventricular arrhythmias in patients with COPD are associated with QT dispersion. Chest 2002; 122(6):2055-2061.
31. Stewart AG, Waterhouse JC, Howard P. The QTc interval, auto-nomic neuropathy and mortality in hypoxaemic COPD. Respir Med 1995; 89:79-84.
32. Lacasse M, Maltais F, Poirier P, Lacasse Y, Marquis K, Jobin J, LeBlanc P. Post-exercise heart rate recovery and mortality in chronic obstructive pulmonary disease. Respir Med 2005; 99(7):877-886.
33. Marquis K, Maltais F, Lacasse Y, Lacourcière Y, Fortin C, Poirier P. Effects of aerobic exercise training and irbesartan on blood pressure and heart rate variability in patients with chronic obstructive pulmonary disease. Can Respir J 2008; 15:355-360.
34. Scalvini S, Porta R, Zanelli E, Volterrani M, Vitacca M, Pagani M, Giordano A, Ambrosino N. Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary disease. Eur Respir J 1999; 13:119-124.
35. Bartels MN, Gonzalez JM, Kim W, De Meersman RE. Oxygen supplementation and cardiac-autonomic modulation in COPD. Chest 2000; 118:691-696.
36. Marquis K, Maltais F, Duguay V, Bezeau AM, LeBlanc P, Jobin J, Poirier P. The metabolic syndrome in chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005; 25:226-232.